Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/112008
Title: | Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis. |
Author: | Graupera, Isabel Solà, Elsa Fabrellas i Padrès, Núria Moreira, Rebeca Solé Padullés, Cristina Huelin, Patricia de la Prada, Gloria Pose, Elisa Ariza Cardenal, Javier Risso, Alessandro Albertos, Sonia Morales Ruiz, Manuel Jiménez Povedano, Wladimiro Ginès i Gibert, Pere |
Keywords: | Cirrosi hepàtica Orina Creatina Inflamació Ascites Hepatic cirrhosis Urine Creatine Inflammation Ascites |
Issue Date: | 30-Jun-2016 |
Publisher: | Public Library of Science (PLoS) |
Abstract: | MCP-1 (monocyte chemoattractant protein-1) is a proinflammatory cytokine involved in chemotaxis of monocytes. In several diseases, such as acute coronary syndromes and heart failure, elevated MCP-1 levels have been associated with poor outcomes. Little is known about MCP-1 in cirrhosis. AIM: To investigate the relationship between MCP-1 and outcome in decompensated cirrhosis. METHODS: Prospective study of 218 patients discharged from hospital after an admission for complications of cirrhosis. Urine and plasma levels of MCP-1 and other urine proinflammatroy biomarkers: osteopontin(OPN), trefoil-factor3 and liver-fatty-acid-binding protein were measured at admission. Urine non-inflammatory mediators cystatin-C, β2microglobulin and albumin were measured as control biomarkers. The relationship between these biomarkers and the 3-month hospital readmission, complications of cirrhosis, and mortality were assessed. RESULTS: 69 patients(32%) had at least one readmission during the 3-month period of follow-up and 30 patients died(14%). Urine MCP-1 and OPN levels, were associated with 3-month probability of readmission (0.85 (0.27-2.1) and 2003 (705-4586) ug/g creat vs 0.47 (0.2-1.1) and 1188 (512-2958) ug/g creat, in patients with and without readmission, respectively; p<0.05; median (IQR)). Furthermore, urine levels of MCP-1 were significantly associated with mortality (1.01 (1-3.6) vs 0.5 (0.2-1.1) μg/g creat, in dead and alive patients at 3 months; p<0.05). Patients with higher levels of urine MCP-1 (above percentile 75th) had higher probability of development of hepatic encephalopathy, bacterial infections or AKI. Urine MCP-1 was an independent predictive factor of hospital readmission and combined end-point of readmission or dead at 3 months. Plasma levels of MCP-1 did not correlated with outcomes. CONCLUSION: Urine, but not plasma, MCP-1 levels are associated with hospital readmission, development of complications of cirrhosis, and mortality. These results suggest that in cirrhosis there is an inflammatory response that is associated with poor outcomes. |
Note: | Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0157371 |
It is part of: | PLoS One, 2016, vol. 11, num. 6 |
URI: | http://hdl.handle.net/2445/112008 |
Related resource: | https://doi.org/10.1371/journal.pone.0157371 |
ISSN: | 1932-6203 |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
666256.pdf | 763.75 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License